Literature DB >> 31954768

Protective impacts of erythropoietin on myelinization of oligodendrocytes and schwann cells in CNS and PNS following cuprizone-induced multiple sclerosis- histology, molecular, and functional studies.

Jafar Mirzaie1, Amir Raoofi2, Zahra Jamalpoor3, Akram Nezhadi4, Rahim Golmohammadi5.   

Abstract

BACKGROUND: Multiple sclerosis (MS) is known as one of the chronic inflammatory diseases characterized by lesions in the central nervous system (CNS) and peripheral nervous system(PNS) resulting in serious cognitive or physical disabilities as well as neurological disorders. Thus, protective effects of erythropoietin(EPO) on myelinization of oligodendrocytes and schwann cells respectively in CNS and PNS following MS induced by cuprizone (CPZ) administration in young female mice.
METHODOLOGY: To meet the objectives of this study; a chow with 0.2 % CPZ was used to feed young female C57BL/6 J mice for six weeks. After three weeks, EPO (5000 IU/kg body weight) was administered via daily intra-peritoneal injection for simultaneous treatment of the mice. Measurement of latency and amplitude of the compound muscle action potential (CMAP) of gastrocnemius muscle was also performed every week during a six-week demyelination interval, and then examinations were fulfilled on the histological sections of the brain and sciatic nerve. Therefore, we focused on the removal of the sciatic and sciatic nerve specimens and analysis of the use of the stereological procedures, western blot, immuno-histochemistry, and gene expression.
RESULTS: According to the results of this study, MBP levels increased in oligodendrocytes (OLs) in the treated mice. Moreover, EPO could concurrently enhance motor coordination and muscle activity. Analysis showed the significant enhancement of the gene expression of MBP, MAG, and S100, as well as stereological variables in the treatment group in comparison with the cuprizone (CPZ) group.
CONCLUSION: Findings could help further understand the alleviation of the detrimental impacts of CPZ using the OLs that would be capable of increasing the level of S100, MAG, and MBP.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CNS; Cuprizone; Demyelination; Multiple sclerosis; PNS

Year:  2020        PMID: 31954768     DOI: 10.1016/j.jchemneu.2020.101750

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  3 in total

1.  Combination effects of mesenchymal stem cells transplantation and anodal transcranial direct current stimulation on a cuprizone-induced mouse model of multiple sclerosis.

Authors:  Sina Mojaverrostami; Farnaz Khadivi; Davood Zarini; Alireza Mohammadi
Journal:  J Mol Histol       Date:  2022-08-10       Impact factor: 3.156

Review 2.  Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020.

Authors:  Niklas Huntemann; Leoni Rolfes; Marc Pawlitzki; Tobias Ruck; Steffen Pfeuffer; Heinz Wiendl; Sven G Meuth
Journal:  Drugs       Date:  2021-06-04       Impact factor: 9.546

3.  Visual Evoked Potentials to Monitor Myelin Cuprizone-Induced Functional Changes.

Authors:  Silvia Marenna; Su-Chun Huang; Gloria Dalla Costa; Raffaele d'Isa; Valerio Castoldi; Elena Rossi; Giancarlo Comi; Letizia Leocani
Journal:  Front Neurosci       Date:  2022-04-15       Impact factor: 5.152

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.